Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Metastatic Pancreatic Adenocarcinoma · Primary Biliary Cholangitis

Ipsen

Ipsen trial registry — 27 ClinicalTrials.gov studies with program phase, status, and indication context.

Website Investor relations
70, Rue Balard, Paris, Île-de-France 75015, FR HQ
6,584 Employees
NMPA registrant Type
Company details
Status
Public
HQ
70, Rue Balard, Paris, Île-de-France 75015, FR
Employees
6,584
Programs
27
Drugs
36
Patents
0
Official website ↗ All projects Drug pipeline News & analysis
Intelligence · Clinical Trials

Ipsen clinical trials

Registry index of 27 ClinicalTrials.gov studies linked to Ipsen programs — each row shows trial ID, program name, phase, status, and indication.

Ipsen trial registry — 27 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Ipsen.

  1. CLIN-10200-458 — Phase 3

    Clinical update

  2. CLIN-52120-464 — Phase 3

    Clinical update

  3. CLIN-52120-463 — Phase 3

    Clinical update

  4. CLIN-52120-452 — Approved

    Clinical update

  5. CLIN-01194-450 — Phase 2

    Clinical update

  6. A4250-015 — Phase 3

    Clinical update

  7. F-FR-60000-023 — Phase 2

    Clinical update

  8. D-US-60010-001 — Phase 3

    Clinical update

Trial registry

27 studies
  15. 2024-514479-16-00

    F-FR-60000-023

    Phase 2 active small_molecule

    Unresectable, Locally Advanced or Metastatic Renal Cell Carcinoma with a Clear-Cell Component Who Progressed After 1st Line Treatment with Checkpoint Inhibitors

    CTIS ↗

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.